These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30040595)

  • 1. Validation of the Change or Stop Testosterone-Lowering Medication (COSTLow) Scale Using the Delphi Method Among Clinical Experts.
    Briken P; Turner D; Thibaut F; Bradford J; Cosyns P; Tozdan S
    J Sex Marital Ther; 2019; 45(2):148-158. PubMed ID: 30040595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R Scale.
    Wolba J; Tozdan S; Briken P; Freese R; Retz W; Turner D
    J Sex Med; 2023 Mar; 20(4):549-558. PubMed ID: 36861326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Dekker A; Briken P
    World J Biol Psychiatry; 2014 Aug; 15(6):472-8. PubMed ID: 24219802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
    Sauter J; Rettenberger M; Briken P; Turner D
    J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders.
    Thibaut F; Cosyns P; Fedoroff JP; Briken P; Goethals K; Bradford JMW;
    World J Biol Psychiatry; 2020 Jul; 21(6):412-490. PubMed ID: 32452729
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of testosterone in sexuality and paraphilia--a neurobiological approach. Part II: testosterone and paraphilia.
    Jordan K; Fromberger P; Stolpmann G; Müller JL
    J Sex Med; 2011 Nov; 8(11):3008-29. PubMed ID: 21797985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Failure of a study in forensic psychiatric hospitals : Clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy].
    Briken P; Müller JL; Berner W; Bödeker RH; Vollmann J; Kasperk C; Koller M
    Nervenarzt; 2017 May; 88(5):480-485. PubMed ID: 28289788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on guidelines for the pharmacological treatment of paraphilic disorders.
    Krueger RB
    World J Biol Psychiatry; 2020 Jul; 21(6):409-411. PubMed ID: 33019868
    [No Abstract]   [Full Text] [Related]  

  • 14. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
    Saleh FM; Berlin FS
    J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of men with paraphilia.
    Bradford JM
    N Engl J Med; 1998 Feb; 338(7):464-5. PubMed ID: 9459652
    [No Abstract]   [Full Text] [Related]  

  • 16. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    Depress Anxiety; 1999; 9(3):107-16. PubMed ID: 10356648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for youth paraphilic disorders: opportunities to reduce harm.
    Kasinathan J
    Australas Psychiatry; 2017 Apr; 25(2):121-125. PubMed ID: 27856768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of a tool for withholding and withdrawing life-sustaining treatment in the emergency room].
    Chirac A; David G; Rieg N; Schott-Pethelaz AM; Bohe J; Carpentier F; Jacob X; Rhondali W; Filbet M
    Ann Fr Anesth Reanim; 2014 Nov; 33(11):555-62. PubMed ID: 25450728
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.